Home > News > Protiveris Received MIPS Award for Technology Optimization
April 1st, 2004
Protiveris Received MIPS Award for Technology Optimization
Protiveris Inc., a bio- nanotechnology company commercializing bioMEMS technologies to facilitate protein research and the discovery of new pharmaceuticals, today announced that it is a recipient of a $116,000 award from the Maryland Industrial Partnerships (MIPS) program. This award is to be used for the optimization of microfluidic sample delivery system in the VeriScan(TM) 3000 -- the Company's patent pending biosensor system for advanced biological and chemical detection.
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc. April 7th, 2014